HISTORY

Olive Medical Corporation was founded in Sandy Utah in October of 2009. The founders came from diverse product development backgrounds in the medical, entertainment, and aerospace fields.

Olive Medical is dedicated to reducing the cost of surgical imaging equipment by using a combination of superior technology, vertical integration, and lean development.

The OVB1 HD Camera Control Unit, in combination with the TCK1 Camera Head, delivers an image quality equivalent to or better than leading endoscopic cameras while staying within budget constraints.

MANAGEMENT

Josh Talbert, Chief Executive Officer, Boardmember

Mr. Talbert leads the company as Chief Executive Officer and is a member of the Board of Directors. He has held these roles since the Company's founding in 2009. Mr. Talbert has also led the Company through several equity financing rounds. In addition to driving financial goals, he has established both domestic and international sales and marketing channels for the Company. Prior to joining Olive Medical, Mr. Talbert specialized in software design, algorithm development for military surveillance aircraft, video processing, and hardware design for a Fortune 500 medical device company in the Bay Area. Talbert holds both a BS and MS in Electrical Engineering from the University of Utah and currently has 2 issued patents and 10 patents pending.

Mark Albrecht, Vice President of Sales

Mr. Albrecht has a proven record of accomplishment with over 25 years of experience in the medical device industry with positions including Vice President of Sales, National Accounts, and Marketing for companies ranging in size from Fortune 500 corporations to venture capital funded start-up firms. Mr. Albrecht has built successful sales teams at multiple companies, and has negotiated numerous national and regional contracts with the nation's leading healthcare providers. He holds a BA in Business Administration from the University of Cincinnati.

Jeremiah Henley, President, Boardmember

Mr. Henley has over three years experience with a major medical device corporation before Olive. His main responsibilities were product design and project management. In that time he successfully brought five high-profile products to market, including a high-definition surgical camera system and an industry-first surgical light source. In addition to managing these projects he introduced DFMA best practices, developed manufacturing and quality control procedures, and led the implementation of a CAD library system. Previously, Mr. Henley gained nearly two years experience in telecommunications product design and development with Alcatel USA. He holds a BS in Mechanical Engineering from the University of the Pacific.

Donald Wichern, Chief Technology Officer

Mr. Wichern has more than three years experience developing hardware and software for medical video systems in a leading medical device corporation before Olive, with an emphasis in high speed signal routing and video processing. As the lead electrical engineer, he successfully brought two generations of the leading high-definition surgical camera to market. Mr. Wichern began his focus on medical devices during his Master's program, where his thesis developed a non-invasive method of measuring cranial pressure. He holds a MS in Electrical Engineering from Brigham Young University

J. Michael Brown, Chairman of the Board

Mr. Brown is currently CEO of Wolfe Tory Medical, Inc. in Salt Lake City, Utah, and has over 25 years experience starting and managing medical device start-up companies. He has a proven history of success with a range of general executive roles and responsibilities, but focuses an emphasis on creating markets using product innovations. Mr. Brown has raised more than $25 million for his current and past companies, and has had four of his previous start-ups acquired by larger medical device manufacturers.

S. George Simon, Boardmember

Mr. Simon is currently President and CEO of MediProPharma, Inc. and has over 20 years of worldwide business development, licensing and product development experience with numerous life science companies. Most recently, Mr. Simon was Executive Vice President at Myriad Genetics, Inc. where he was responsible for business development and licensing for the research, diagnostic, and pharmaceutical divisions of a NASDAQ-listed "Top 25" biotechnology company. During his seven year tenure, he negotiated numerous collaborative research, license, joint venture agreements and acquisitions.

Trent Loveless, Chief Financial Officer

Mr. Loveless has a MS in accounting and is a CPA with nearly 20 years of accounting and financial management experience. His background spans multiple industries and he has served in executive management positions in companies ranging from start-up to $750 million in annual revenues. He currently serves as CFO on an outsource basis for a number of domestic and international businesses with a focus on medical device companies. Mr. Loveless has significant experience in debt and equity financings.